ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000613.1|Thiomuracins_1 # 1 # 1212 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.682	BGC0000613.1|Thiomuracins_1 	1	1212	-	Loose	400	27.335	ParR	29.85	3005068	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; Outer Membrane Porin (Opr)	ATGACCAAGCCCCTGCTGATCTACGCGAACGTCCCCTTCTGCAACTCCAAGTGCCACTTCTGCGACTGGGTGGTCCAGGTCCCCGTACGCGACCTGCGGCTGGGCGAGCAGAGCCCGGGCCGCGTCGCGTACCTGGAGGCCATCAGGACCCAGATCCGCGTCCAGGCCCCCGCCCTGCGCGAGCACTACCACCCCGACATCGTCTACTGGGGCGGCGGCACGGCCAGCATCCTCGGCCCCCACGAGATCGAGTCCCTGTACGGCACGCTGTCCGCCGAGTTCGACCTGAGCACGGTCAGGGAGGCCACGATCGAGGGCAGCCCGGAATCCCTCGACCGGGACAAACTACGCCTCCTGCGCGAGCTGGGCTTCAACCGGATCAGCATCGGCGTCCAGTCCTTCGACGACGCGCGCCTGCGCCGCCTCGGCCGCGCCCATGCCGCCGACCAGGCCCTCACCGCCGTCCAGGACGCCCACGAGGCCGGCTTCACCAACATCAACATCGACCTGATCGTCGGCTTCCCCGGGCAGACCGGCCAGGAGGTCGCCGACTCGGTCCGCACGGCCCTGACCCTGCCCATCAACCACTTCTCGATCTACCCCTACCGCGCCAGCCCCGGCACGGTGCTGCGCAAGCAGGTCCACCGGGGCGCCCAGCTCGACCTCAACCTCCAGCTCCAGGCGTACGGCATCGCCAGGGAACTGCTGGAAGCAGCCGGCTTCCCCGAATACGCCATGTCCTACTTCGGCCACCCCCGCTGCCAGTCGGACGAGGCGTACTACCAGCTCCGCATGGACTGGATCGGCTTCGGCTCGGGCGCCAACTCCCTGATCGGCCGCCGCTACCTGAGCTACGAGAAGGGCAAGCTGGCCCACTACAACACCAACCCGCTGGCCTTCGACATCAACGCCCCGGCCCACTCCCCACAGCTCACCCTCCACTTCCTGTCCCAGGCACTGACAACCGCCGAGGGCCTGGACGCCCGCCTCTACCAGCAACGCACCGGCGTCCCCCTCCGCACGGCCTGCTCTCACCCGGAGGTCATGACGTACCTGGAACGCATGAACAACCACGGCCGGCTCATCGCCGACCACAACGGCATCCGCCTCCACCGCGACGACATCGCCCAGACCTTCATCGCCCTCAACTGGATCCCCACCCCCGACACCACCCCCAACGAGGTAATCCCCCTAACCCCCTCACCCACCTAG	MTKPLLIYANVPFCNSKCHFCDWVVQVPVRDLRLGEQSPGRVAYLEAIRTQIRVQAPALREHYHPDIVYWGGGTASILGPHEIESLYGTLSAEFDLSTVREATIEGSPESLDRDKLRLLRELGFNRISIGVQSFDDARLRRLGRAHAADQALTAVQDAHEAGFTNINIDLIVGFPGQTGQEVADSVRTALTLPINHFSIYPYRASPGTVLRKQVHRGAQLDLNLQLQAYGIARELLEAAGFPEYAMSYFGHPRCQSDEAYYQLRMDWIGFGSGANSLIGRRYLSYEKGKLAHYNTNPLAFDINAPAHSPQLTLHFLSQALTTAEGLDARLYQQRTGVPLRTACSHPEVMTYLERMNNHGRLIADHNGIRLHRDDIAQTFIALNWIPTPDTTPNEVIPLTPSPT	MDCPTLSKVLLVEDDQKLARLIASFLSQHGFEVRQVHRGDAAFAAFLDFKPQVVVLDLMLPGQNGLQVCREIRRVANLPILILTAQEDDLDHILGLESGADDYVIKPIEPPVLLARLRALMRRHAPLPASPESLTFGKLNIDRRRREAELEGLGIELTTMEFELLWLLASQAGEILSRDEILNQIRGIGFDGLNRSVDVCISKLRNKLKDNPREPVRIKTVWGKGYLFNPLGWEL	171.49	gnl|BL_ORD_ID|2791|hsp_num:0	3806			39	240	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; imipenem; chloramphenicol; norfloxacin; ofloxacin; gentamicin
BGC0000613.1|Thiomuracins_2 # 1209 # 2372 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.702	BGC0000613.1|Thiomuracins_2 	1209	2372	-	Loose	1450	25.7942	BahA	41.94	3003984	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic inactivation	Bah amidohydrolase	ATGACGGCCCCCGTAAGGCCACCTTCGGTCACGGACGGCGGGACGTCCCTGTTCGCCTGGCTGCGCGAGATGCGCGACACGCACCCGGTCTGGCGGGATTCCTATGGGATGTACCACGTCTTCCGCTACGACGACGTACGCGCCGTTCTGGCGGACCACGAGCGGTTCTCCTCCGACCGCACCAGGCTGATGGGACGGCAGCCGTTCGGCCAGGGCGGCATCACGATGATCGACCCGCCCGAACACCGCCACCAGCGCAGGCTCATCACCGCGGCCTTCACCCCGAGCTCCGTCGCGGCCCTCGAACCACGCATCGCCGCGATCGCCGACGAGCTCCTCGACGCCCTGCCCGGCCCTGACTTCGACCTGGTCGAGAGCCTGGCCTATCCCCTGCCCGTCACCGTCGTCGCCGAGCTGCTCGGCGTGCCGCCGTCCGACCGCGACCTGTTCCGCACCTGGTCGGACCGGCTCATGTCGCTCCAGGTGCCCGACTTCGCCGACCCGTCGCTGGCCGGGCGGGTGGCGGCGGCCATGGCGGAGATGAACGACTACCTGCGCGAGCACTGCGCGGACCGCCGTACCCGTCCCAGGGACGACCTGCTCACCCGCCTCGTCCATGCCGAGATCGACGGCGAGCGGCTCGACGCGGAGCAGGTCGTCAACACCGCGAGCCTGCTCCTGCTGGCCGGGCACGTCACCACCACCGTGCTGATCGGCAACACCGTGCTCTGCCTGGCGGACGCCCCCGAGGCCGCCCACCGGACAAGAGCCGACATGTCGCTCATCCCCCAGGCGCTGGAGGAGAGCATGCGCCTGCGCTCGCCGTTCATGCAGGCGGGCAGGGTGACCACGCAGGACGTACAGGTGGCCGGCGAGACCATCCCGGCCAACAGGTTCGTCATGGCCTGGCTCCTGTCCGCCAACCACGACGAACGCCACTTCGCCGACCCCGAACGCTTCGACCTGGACCGGCAGCTCACCGGCCAGCTCGCGTTCGGCCACGGCGTGCACTTCTGCCTGGGCGCCCAGCTCGGGCGCCTGGAGGGCCGCATCGCGCTGGAGCGCCTGCTGAGCCGCTTCACCGAGCTCCGTCCCGAAAAGCGCTCCTTCTACGAGAGCCAGATCTTCGGCGTCAGGGAGATGCACGTGAGAGGTTCCTCATGA	MTAPVRPPSVTDGGTSLFAWLREMRDTHPVWRDSYGMYHVFRYDDVRAVLADHERFSSDRTRLMGRQPFGQGGITMIDPPEHRHQRRLITAAFTPSSVAALEPRIAAIADELLDALPGPDFDLVESLAYPLPVTVVAELLGVPPSDRDLFRTWSDRLMSLQVPDFADPSLAGRVAAAMAEMNDYLREHCADRRTRPRDDLLTRLVHAEIDGERLDAEQVVNTASLLLLAGHVTTTVLIGNTVLCLADAPEAAHRTRADMSLIPQALEESMRLRSPFMQAGRVTTQDVQVAGETIPANRFVMAWLLSANHDERHFADPERFDLDRQLTGQLAFGHGVHFCLGAQLGRLEGRIALERLLSRFTELRPEKRSFYESQIFGVREMHVRGSS	MEIHKEKEKEKGVTFFRRIMANRKRRGPLSPGWKGASLGLGATGFILILIQANYLLTGHGVGKFIVGTFLFLFAAALISGLASMLLHGVKKLPSRYIWMLLYSLIMFLFCFIVQPGVSAVFIVSLAIVLSLFGALAYKFAAGSYKQVSKTRKIGAMACLSLITIAIGAGSFWLIRAGDDAAPDITLKQLKTSTRYEDSTMNNPAEQGTYPVQSLLYGSPDNYRTEFNQSGSLTTQTVDASRFVEKWSSLRTKSLGFGPEAMPLNGRVWYPEGEGTFPLVLIVHGNHLMNDYSDPGYEYLGRLLASKGYIFVSVDENFLNFSPYEDLFLISPLLSENPARGLLLLEHLQTWKDWNSDPDNPFYQKVDMERIALIGHSRGGEAVAIAAAYNKLGRHPDHGDIKFDYNFSIRSLISIAGTDGQYKPQGKPLPLQDVNYLSLHGAHDMDVNSLDGAKQYHRIRYTKGTNYMKSLVYIYGANHGQFNGGWGRGDGAGLGNQLFNLRQIMPRDEQETIAKVFISSFLDATLKDQRQYREVFKDLGYAKEWIPDNLYVGNYYDSQTTLIADFHEDIDLQSTTLPGGSLRGENLQQWKEEKVKTKWGEADYSAVRLGWNSNGSSEPASYTVTLPDNGVETGRDSSIVFSLADARKTEESGDPKELINFTITVEDRKGHQASLPLSHISKLPPVIEGKLLKWPFSNAGNTSEPVFQSYDFQLDDYYKMNPDFNPQQLSKIRIEFNLTKRGSILLRDVGIRS	51.46	gnl|BL_ORD_ID|2229|hsp_num:0	2521			666	738	bacitracin
BGC0000613.1|Thiomuracins_3 # 2369 # 3589 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.690	BGC0000613.1|Thiomuracins_3 	2369	3589	-	Loose	500	25.409	RSA-2	25.0	3004445	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	RSA beta-lactamase	GTGAACGAGACACACGTCCCGCCGGACCCGACGATGACGATGCCGATCGACTCCCGGCCGCGCATCAAGGACGGCGGCCAGACCCTCCTCAAGTGGCTCGGCACGATGCGGGACGAACAACCGGTCTGGCGCGACGCATTCGGCATCTTCCACGTTTTCCGGCATGCGGCCGTACAGCGGGTGATGTCGGACTATGCGGCGTTCTCCTCTGACATCAACCGGCTCCGGCCCGGCGGCGATCCGTTCAGCGCGGGCAGCCTCATGCTCACCGACCCGCCGGAGCACCGAAAGCTCCGCAAACTCATCAGCCAGGCGTTCACCCCGAAAATGTCGTCGGACATGGTGCCGCGGATCGCCGAGCTCACCACGGCGCTGCTGGACGAGATCGACGAGGACGAGTTCGACCTGGTCGAGAAGATCGCCCACCCGCTGCCCGTGATGGTGATCGCCGAGCTGCTCGGCATTCCGATCCACGACCGCGAGCTGTTCCGCACCTGGGCCGACCGGCTGGTCGCACTGCACGTCGAGGACCCGCGGGACATCGAGATCGGGCGGATGGTCGGTCAGGCCATGCGCGAAATGGGGGAATACGTCCTCACCCACGTGCGCGAGCGCCGCACCCGTCCGCAGGACGACCTCGTCAGCCGGCTGGTCGCGGCCGAGGTGGACGGCGACCGGCTCACCGACGCCGAGATCGTCAACTCCGCCTGCCTGCTGCTGCTCGCCGGGCAGATCACCAGCACGATGGCCCTGGGGAACGCGTTCCTGTGCTTCCGCGACGCGCCCGGCGTGGAGAGCGCCGTACGGGCCGACCGGGAGCTGATCGCACCCGCCTTCGAGGAGGTGCTCAGGCTGCGCCCGCCGCTCACCCAGGCCGCCCGGCTCCCCACGGCCGACGTCGAGATCGACGGCACGCCGATCCCGGCCGGTTCCATGGTCATCAACTGGCTGCTGTCCGCGAACTACGACGAGCGCCAGTTCCCCGACCCGTACCGGCTCGACCCCGGCCGCCAGCCCAACCGCCAGTACGCCTTCGGCCACGGCATCCACTTCTGCCTGGGCGCGCCGCTGGCGAGGGTGGAGGGGAAGGTGGCGCTGGAGCTGGTGTTCGACCGGTTCGAGCAGGTCGAGATCGACCCGGACGCGGAGCTGTCGTACTACGAGGACCCCATGTTCGGCGTCAAGAGCCTGCCGGTACGCGTCAAGCGGGCGCCCCGATGA	MNETHVPPDPTMTMPIDSRPRIKDGGQTLLKWLGTMRDEQPVWRDAFGIFHVFRHAAVQRVMSDYAAFSSDINRLRPGGDPFSAGSLMLTDPPEHRKLRKLISQAFTPKMSSDMVPRIAELTTALLDEIDEDEFDLVEKIAHPLPVMVIAELLGIPIHDRELFRTWADRLVALHVEDPRDIEIGRMVGQAMREMGEYVLTHVRERRTRPQDDLVSRLVAAEVDGDRLTDAEIVNSACLLLLAGQITSTMALGNAFLCFRDAPGVESAVRADRELIAPAFEEVLRLRPPLTQAARLPTADVEIDGTPIPAGSMVINWLLSANYDERQFPDPYRLDPGRQPNRQYAFGHGIHFCLGAPLARVEGKVALELVFDRFEQVEIDPDAELSYYEDPMFGVKSLPVRVKRAPR	MIKKIISGACLVLLAGCVLGVKPAGKETGFMIDSGRFAGMDGCAIVFDARMGKIAGVYGEKRCKERVTACSTFKVPLALMAFDSGVLSDESTVLKWDGVQWPFDSWNQDQTAASWLRNSVVWYSQRLTPMLGLEKIKAYLKAFDYGNQDFSSGLTSAWLTITKSDTNPDKGSLKISAYEELEFFRRFWRGALPVSGAAVEKTKKMIYLETSPGGYALHGKTGSGYLDGLTGDFGWFAGHVEGKGREYFVVTAVTRNGNAADARIPGLVAKELAKNILKDNSVW	143.46	gnl|BL_ORD_ID|2494|hsp_num:0	2885			9	327	
BGC0000613.1|Thiomuracins_4 # 3600 # 4331 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.620	BGC0000613.1|Thiomuracins_4 	3600	4331	-	Loose	400	38.891	nalC	29.7	3000818	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCACCGTCTCGACACGCAGCACGGGTGCCAGGACCAGCGACGATCGCGTACGCCGGACTCTGGACGTCACCAGGAGCCTGCTCCTGCGATCCGGCTACAAGCGGACCACGATGGACGAGATCGCCCGGCGGGCGGACATCGGAAAGGGCACCATTTATCTCAGCTGGGACACGAAAGACGATCTCATAAGAACGCTCGTCATTCAGGAAATTGTCGGAGTCTGCCAGGATATTTCGCGAATAGCGGTGCTTCGTCCTGCCGTCGCGCGGCTCTCCGAGTTCTCACGCGAGCTGTTCACACTCGTGTTCAAGTATCCACTCTTCCGAGCACTCTACACCTATGACAAGGAAACGCTCGGAAGGGCCTGCGACGATCCACAGCTCGGCTTCCAGTGTTACCGCTTCACCACGTTCACGCCATTTCGCGATTATCTCCGGATGCTCCACGAGAGCGGAATGTGGGACCCGTCCCACGGTTTCGCGCTCGATGCCCTGCTTTCCGGGTTCATCAAACTTCACCTGCACGCCGAGATCGCCGGGGCGAAACCCGATCTGGCGGCGCACGCCGACAGCCTGGCCGGCCTCATCAGGAGCTCTTTCGAACCTGCTGACCAGGTCCCGGCCGAAGAACTGACCGACCCCGCCCGCCGTACCGTCGAGATCTTCGACGGCGCCGCGGCGAAATACCGGGCGAAACTCATCCCCCAGCCCCTGGCCGCCTCCGTCTGA	MSTVSTRSTGARTSDDRVRRTLDVTRSLLLRSGYKRTTMDEIARRADIGKGTIYLSWDTKDDLIRTLVIQEIVGVCQDISRIAVLRPAVARLSEFSRELFTLVFKYPLFRALYTYDKETLGRACDDPQLGFQCYRFTTFTPFRDYLRMLHESGMWDPSHGFALDALLSGFIKLHLHAEIAGAKPDLAAHADSLAGLIRSSFEPADQVPAEELTDPARRTVEIFDGAAAKYRAKLIPQPLAASV	MNDASPRLTERGRQRRRAMLDAATQAFLEHGFEGTTLDMVIERAGGSRGTLYSSFGGKEGLFAAVIAHMIGEIFDDSADQPRPAATLSATLEHFGRRFLTSLLDPRCQSLYRLVVAESPRFPAIGKSFYEQGPQQSYLLLSERLAAVAPHMDEETLYAVACQFLEMLKADLFLKALSVADFQPTMALLETRLKLSVDIIACYLEHLSQSPAQG	114.08	gnl|BL_ORD_ID|2127|hsp_num:0	1670			39	333	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; panipenem; trimethoprim-sulfamethoxazole
BGC0000613.1|Thiomuracins_7 # 7475 # 8290 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.730	BGC0000613.1|Thiomuracins_7 	7475	8290	+	Loose	500	25.0238	OXA-12	26.47	3001407	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAGCTGGGTGAGCGTGCACGTCTTCTCGCAGGGGCCGCTCGACGACATGATCACGGGCCTGGCCGGGCCGCTCCTCGGCGACGACGGCTTCTTCCTGCGCTACTGGGAGGGCGGCCCGCATCTGCGGATCAGGGTCAGGTCCCACCCGGCGGAGCAGGTCGTCGAGCGGGCCGAGGCGTATCTGCGCGAGCACCCGTCAGAGGCGGTGATCGACCCGGAGGAGTACGCCAGGCTCGCCGCGACCCTCGCCGCCCGCGAAGGCGTCCCCGGCTATACGCGGCGCCTCTATCCGAACGACTCCGCCCACCTCATCCCGTACCAGCCGGAACACGACCGCTACGGCACGGGCCGCTCGCTCGACGCCGTGGAGCGGCACTTCCACGACTCCAGCGTGATCGCACTCCAGCTGATCGGGGCGGGGCTCGGACACGAGCGGCGGAGCATGGCGTGGCTGACCATGCTGCTGGTCGCCTGGCAGGTCGCGGGGGAGGGCAGGGCGTTCGGCCCGCCCGCTGACGCCGGGGTTCAGGTGCCCCACGAGCGGATGGCGGCGCTGGTCGAGCACGCCAGGGCGGTGACACAGGAGCCTGCGCCGAGCGAGCCCCGTGGCGTGGTGGCCGCCTGGTACGCCTCGATCGCGCGGCTGGTGGAGGAACTGGCGGCGGCGGGGTTCGACGCGGCGCGGACGGGGGCGACCGTCGATCTGGCCGCGCATCTGCTGGCCAACAGGCTGGGGATCCGGGTGCAGGAGGAGGCCCGGCTGCGTCACCTGGCGTCCGGGGCCACGAGGGAGTCGGAGGTGGGGGTCGGATGA	MSWVSVHVFSQGPLDDMITGLAGPLLGDDGFFLRYWEGGPHLRIRVRSHPAEQVVERAEAYLREHPSEAVIDPEEYARLAATLAAREGVPGYTRRLYPNDSAHLIPYQPEHDRYGTGRSLDAVERHFHDSSVIALQLIGAGLGHERRSMAWLTMLLVAWQVAGEGRAFGPPADAGVQVPHERMAALVEHARAVTQEPAPSEPRGVVAAWYASIARLVEELAAAGFDAARTGATVDLAAHLLANRLGIRVQEEARLRHLASGATRESEVGVG	MSRLLLSGLLATGLLCAVPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALMGYDSGFLVNEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYTANILKVSEVEGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASIKAKEEVLAALPAQLKKL	102.65	gnl|BL_ORD_ID|169|hsp_num:0	186			147	351	cloxacillin; oxacillin; cefalotin
BGC0000613.1|Thiomuracins_8 # 8287 # 9246 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.730	BGC0000613.1|Thiomuracins_8 	8287	9246	+	Loose	800	25.0238	adeG	26.88	3000778	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCTGGACGCGGCTGCGGGTGGACTATCACGACGGCCCGATGGACGACCTCATCCTGGACGCGCTCCGCCCGGCCTGGCATGAAATACGGGGATATTTCCTGCGCCACTGGGTGTGCGGCCCGCACCTGCGGATCTTCGTGGACGGCGACGCGACGCCGATCGTCCGGGCGGTCGAGCGCCACCTGGCCGCCTGCCCGTCCGCCGGCACCACCGACCCGCAGGCGCTGCTCCCCCTGCACGAGCGCCTGGCCGAGCTGGAAGGCGAACGAGGCCCGCTGCTGCCATGGGCCCCCGACAACACCGTCACCGCCGAACCCCCGGGGCTCGACACCGAGCTCGACCGGTTCCTCGCGGACTTCTACGCCGACACCACCGAGGCCGCGTTCGACGCCCTCGGCCGGGTCAGAGCCGGCACGCCGCTGCCGGGCATCGCCTTCGACCTGGTGGTCGCCACCGCGCACGACCTGTCGGAGGGCGGCCTGCCCACTGCCAGGACCTCGCTGCGCTCGCACGCCGAGGCTTACCTGTCGCGCCTGCCGGGAGGCGTCCGCGCCAAGTGGCAGGCGCACTACGAACGCAACCAGGAGCCGCTGACCGCCAGGATCAAGGCCCTGACCGGCGCCGGAGAGCCCGGCGCGTGGCTGCGTACGATCCGGGCCACCCGCGACCGGGGCCGTACCCTCATCGACGAGGGACGGCTGAGCCTCGGCTACGCCACCGACGGCCCTTCCACGCGGCCCCCGCTCGCCGCGGTCTCCCCCTTCCACCGGAACCTGGAGACCGACGAACGCTGGCTCGCCCTCAAGGACACCCCCGCCTTCGCCGCCTACCGCCTGGCCCTGAACTGCGCGTACCTCCACCTCACCCGGCTCGGCCTCACGCCCGACCAGCGCTTCCTGATCTGCCACCTCGCCGCGAGCGCCGCCGACGACGTCTACCGGGCCGTGGCCTCATGA	MTWTRLRVDYHDGPMDDLILDALRPAWHEIRGYFLRHWVCGPHLRIFVDGDATPIVRAVERHLAACPSAGTTDPQALLPLHERLAELEGERGPLLPWAPDNTVTAEPPGLDTELDRFLADFYADTTEAAFDALGRVRAGTPLPGIAFDLVVATAHDLSEGGLPTARTSLRSHAEAYLSRLPGGVRAKWQAHYERNQEPLTARIKALTGAGEPGAWLRTIRATRDRGRTLIDEGRLSLGYATDGPSTRPPLAAVSPFHRNLETDERWLALKDTPAFAAYRLALNCAYLHLTRLGLTPDQRFLICHLAASAADDVYRAVAS	MSFSRKQFALSAIFVAILATGGSFMLLHENADAKAAPTAAQQAATVDVAPVVSKTITDWQEYSGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNSAQVPVYMGLANETGFTREGTINSIDNNLNTTSGTIRVRATFDNPNGVLLPGLYARIRLGGGQPRPAILISPTAVGVDQDKRFVVVVDAKNQTAYREVKLGAQQDGLQIVNSGLQAGDRIVVNGLQRIRPGDPVTPHLVPMPNSQITASATPPQPQPTDKTSTPAKG	78.57	gnl|BL_ORD_ID|1125|hsp_num:0	1226			828	1092	tetracycline
BGC0000613.1|Thiomuracins_9 # 9243 # 10529 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.744	BGC0000613.1|Thiomuracins_9 	9243	10529	+	Loose	800	29.261	cprS	40.62	3005064	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration; antibiotic efflux	pmr phosphoethanolamine transferase	ATGACCGGGGAACGGTACGAGCTGCGCGCCGGCGTGCACCTCGCCCGGCTGGACGCGGGGGTCCGCCTGTTCGCCTGGCCGCACGCCGAGACCCTCGGCGAGCTCACGCGGGATGAGCTCGACCTGCTCCGCGACCTGGCCGCCGGACCCCGCACCGCCGGGGGACCGCTCGTCGAACGCCTGCGCGCCGGAGGCTGGCTCAAGATCACGATTACCCGGGACGGCGTGCCCCTCTACACGCTCGCCCCGCTGCGCCCGCCGCCGCCACGGCCGGCGGTGCCGGAGCGGCCGGTTCTGTCCAGGTTCGCCACGCTGCGGCGCGAGGGGGACGCGCTGGTCGCCGGCTCCCCGCTGGCCTGGTGCGACCTGTACGTCCACGACCCCGGCCTGGTCGGCGACGTGGTCCGGCCCGGCGGCGAGGTCCTGGCCGACCTGGTGTGGGCCGGGCTGGCCGTGCCCGAGGAGGCCGAGGACCGGGAGCTGCGGTTCCGGCAGTGGGCGCCGCACGAGCTGGAGTTCCATGACCGGAGCCGGGTGGGGCACCGCGGCTACCTGGGCGATGGGTTCGGCGGGACGTTCTGGGCCCGCGGCCGGTTCGACCCGCTGCCCGCCCGGCCCCGGCCCTACCCCGGCCGGGCGATCGAGCTGCCCACGCCCGACCTGGACGAACTGCGGCTCAAGGACCCCTCGCTCACGGACGTGCTGGAGGGCCGCAGGTCCGTACGCGAGCACGACGACGAGCGCCCGATCACCCTCGACCTGCTCGGCGAGCTGCTGTACCGCACGGCCAGGGTGCGGGAGTGCTGGACGGCCGACGGCGTCGAATACACCCGCAAGCCGTACCCCTCCGGAGGGTCCGTCTACGAGCTGGAGATCTACCCCGTCGTCAGGAACGTGGCCGGGCTCGAACCCGGCATGTACCACTACGACGGGCACGACCACGTGCTCAGGCCGGTACGTGAGGCCGGCCATCCCGCCGTACGCCGGCTGCTGACCGTCGCCGGGCACGGCGCCGCCACCGGCCGCCGCCCCCAGGTCCTGCTCGCGGTCTCCAGCCGCGCCGGCCGGCTGCTGTGGAAGTACGAAGGCATGGGGTACGCGCTGACGCTCAAGCACGTGGGTGTGCTCTACCAGACGCTCTACTGCGTGGCCACGGCGATGGGCCTGGCGGCCTGCGGGCTCGGCAGCGGCGACTCGGCCGCGTTCGCCGAGGCGACCGGGCGGGACCCGTTGGAGGAGTGCGCGGTCGGCGAATTCATGATCGGAACCGCGGAGGCACCACGTTGA	MTGERYELRAGVHLARLDAGVRLFAWPHAETLGELTRDELDLLRDLAAGPRTAGGPLVERLRAGGWLKITITRDGVPLYTLAPLRPPPPRPAVPERPVLSRFATLRREGDALVAGSPLAWCDLYVHDPGLVGDVVRPGGEVLADLVWAGLAVPEEAEDRELRFRQWAPHELEFHDRSRVGHRGYLGDGFGGTFWARGRFDPLPARPRPYPGRAIELPTPDLDELRLKDPSLTDVLEGRRSVREHDDERPITLDLLGELLYRTARVRECWTADGVEYTRKPYPSGGSVYELEIYPVVRNVAGLEPGMYHYDGHDHVLRPVREAGHPAVRRLLTVAGHGAATGRRPQVLLAVSSRAGRLLWKYEGMGYALTLKHVGVLYQTLYCVATAMGLAACGLGSGDSAAFAEATGRDPLEECAVGEFMIGTAEAPR	MKRGLSLIPIVGGGVTLILAGVLLVYTRMLGDYGETGALYLLSMMMEEEGLYFAQRYQEDPATPAPDSYYFKGSVGTAGLPPKLREMLDTPPYKSIGAMQLLGNWDDDDEEEDDDAPSDDAYVVVRQPLADGKTLYLYDNDAAGSIDTPLSDAIIDARVRQTWIVTLSVTLPSLAAVGLLVWFIVAPLRKLTRWSMTLDDLAPDSQRPRFNYRELNVLADTLWNSVTRIKDFSQREERFLRYASHELRTPLAVIGMNLELLDQPGRAPSPHALQRIRRSALGMQQMTETLLWLSRESGELRDDGHIEVGRLLEELLEEQQALSQRRGLTFHLDVEPHSLPQTRARIIIGNLLRNALQYSDEGVVEIVVRDRSLLISNPIGAAQGTEESMAFGYGLGLDLVQRLCQKSGWRLHYSSDEQRFRCELLFPATPD	99.30	gnl|BL_ORD_ID|2789|hsp_num:0	3804			645	741	polymyxin B; colistin A; colistin B
BGC0000613.1|Thiomuracins_10 # 10526 # 12418 # 1 # ID=1_10;partial=00;start_type=TTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.771	BGC0000613.1|Thiomuracins_10 	10526	12418	+	Loose	600	27.335	clbC	31.37	3002816	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	TTGAACGACTTCAAACCCAGACTCCCCGCGGACATACGCTTCGCGCCCACCTCCGGCGGTGTCGCCTTCCTCACCCGCGAAGGCGTCGTGCGGATGAACGGGGCCTCCGTCCACCTGTGGGTGGAGCGGCTGGCCGTGCACCTCGACGGGAGCAGGACCGTGGCCGAGCTGACCGCGGAGCTGCCCGACGAGCGGCGGGCGTTCGTGACGAGCCTGCTGACCACGCTGCGCGAGCGCGGGCTCGTGGAGGACGCGGGAGAGCGCGGCGTGCTGCCCGTGGCGGCCGGCACCGCGTGCTCGCTGCTGGCCGACGCGGACCGGTTCGGCGAGCTGGCGCCCGCCCTGGCCGACGCCCTGCGCAGGCTGGGGCTGGAGGTGCTGACAGAGCCGTCGGGCGGGGCGCTCGTGCACGTCGCGGCGGCCGACGCGGACGGGCTGGCCGCCGCCGGGCGCCTCGACCGGCTGAGCGCCGAGCGCGGGCTGCCCATCGCGCACGTGCTGCTGCGCGAGGGCGAGGCGTGGTGGAGCGAGACCGGCGTCGTCGGGCGCGACGTCCCGCCGTGGGCGGCCGGGTGGCGGCGGCTGGCGGCCATGGAGGCCGTCCCGCGTACCGCCGGGCACGTCTCCGTGTCGCCCGTCGCCGCGGCCGTGGTCGCCGGGCAGGTGGTGGCGGACCTGGGGCGCTGCCTGTCCGGAACGCCCCGCGTGTCCGGCGGTCCGCGGCTGCACGTGGTGGACCTGGACGGGTTCGGGATGCGGACGCACTCCTTCCTGCCGCACCTGTCGGCGCTGCCGCCCGGCACGGGGGTGAGCGCGGGGCCGCTCGGCGAGGAGGAGTTCTCGCGGCGGGCGGCCAGGTTGATGGACTCGCGGACGGGGGTGTTCGCCGAGATCGAGGAGGGGGAGTACGGGCAGCTCCCGCTGCACGTGTCGGTGACCACGGTGGCCGATCCGATGGGGGCCCTCGGGGGTGCGCTGGCGCGGGTGATCGGCGTGGGGGCGGACTTCGCCACCGCGCGATACCGGGCGGCGCTTAAGGCACTGACCGTGCACGGGCTGCTCGCCCTCGACCCCCGCCGCCTGGTCACGGCCGAGGGGACGCCCCTGACCGGCGCGGGGGAACCCGCCAGCGGCTTCCCGGCTGATCCGGGCGCGAGGGAACGGCCGATCGGTGGCTTTTCGGCTGATCCGGGTGCGGGTGAGCGGCCGGACGACGGTCTCCTGGACGACCCGCTGGTGGGCGACGTCGCGGCGGGACGGGTCGAGGCGTTCGTGCGCGGCCGTGACCTCGTCGAGGGCGGTGAGGTGCTGCTGCCCGCCCGCGCGGTGTTCCTGGATCCGCACGCCACCGGGGCCGCCGCGGGGTACTCGGCCGAGGAGGCGCTGGTCGCGGGGTTACTGGACCACTGTGCGGCACTGGCCGGGCTCGACGGGACGCTGCCGCCCGTGGACGTGGGCGGCGCGCGGGCGGCCGACGACGAGACCGCGCGGTCGGCGGCGCTGCTGGACGCGATCGGGCTGCCGTACCAGGTGCTGGACGCCACCGGCCCGTCGGGCGTGCCCGTGCACGCGGGGACGCTCGGCGGGCGGCTGGTGGCGCGGGCGGCGGGCGTCACGCCCCTGGCCGCGCTGCGGGCCACGCTCGAAGGGATCCTGGCCGCGTACCAGGGCATTCCGGGCCCCGCACCCCTGCCCGACCTGTGCCCGGCCGTCGCGCAGGAGCCGCCGGTCGTCCTCGACACGGGGGCGGCCGTGCTCGGCGCCGGTGAGCTCGCCGCCGCCCTGGCCGGCGCCGGGCTGCGGGTCAGCGCCGTTCCGCTGGATCACGACCGGGAGGTACACGCGCTCATGCCGCACGTCGTCCGCGTCGTCACGGAGCCGCTCCATGGCTGA	MNDFKPRLPADIRFAPTSGGVAFLTREGVVRMNGASVHLWVERLAVHLDGSRTVAELTAELPDERRAFVTSLLTTLRERGLVEDAGERGVLPVAAGTACSLLADADRFGELAPALADALRRLGLEVLTEPSGGALVHVAAADADGLAAAGRLDRLSAERGLPIAHVLLREGEAWWSETGVVGRDVPPWAAGWRRLAAMEAVPRTAGHVSVSPVAAAVVAGQVVADLGRCLSGTPRVSGGPRLHVVDLDGFGMRTHSFLPHLSALPPGTGVSAGPLGEEEFSRRAARLMDSRTGVFAEIEEGEYGQLPLHVSVTTVADPMGALGGALARVIGVGADFATARYRAALKALTVHGLLALDPRRLVTAEGTPLTGAGEPASGFPADPGARERPIGGFSADPGAGERPDDGLLDDPLVGDVAAGRVEAFVRGRDLVEGGEVLLPARAVFLDPHATGAAAGYSAEEALVAGLLDHCAALAGLDGTLPPVDVGGARAADDETARSAALLDAIGLPYQVLDATGPSGVPVHAGTLGGRLVARAAGVTPLAALRATLEGILAAYQGIPGPAPLPDLCPAVAQEPPVVLDTGAAVLGAGELAAALAGAGLRVSAVPLDHDREVHALMPHVVRVVTEPLHG	MKVVNHATKYERLKHFLNALNEPTYRYKQITEAIFKHRIGAFNKMTTLPKALRESLINEFGPSILTVEPVLETTSQQVTKVLLKVAGNNQVEAVRMHYEAGWESFCISSQCGCGLGCTFCSTGAIGLKQNLSADEMTDQLLYFYLKGHSLDSVSFMGMGEALANVRIFDALNVLVDRQLFALSPRRITVSTVGIIPNIQRMTSSFPQMNLTFSLHSPFHDQRSELMPINNKYPLDQVMNVLDQHIHETGRKVYIAYVMLRGVNDSEKHAEALVKRILNNRYPHLYHVNLIRYNPTVGTPENYGQTIEEKLQTFYRVVKSARIPVTIRSQFGREIDAACGQLYGQYQAKKR	180.00	gnl|BL_ORD_ID|1512|hsp_num:0	1642			465	618	lincomycin; clindamycin; azidamfenicol; chloramphenicol; thiamphenicol; virginiamycin M1; tiamulin; madumycin II; griseoviridin; dalfopristin
BGC0000613.1|Thiomuracins_11 # 12411 # 14255 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.736	BGC0000613.1|Thiomuracins_11 	12411	14255	+	Loose	500	30.4166	SPG-1	29.03	3003720	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPG beta-lactamase	ATGGCTGAGGTCGTGGGGACGGGCCTGCTGGCCGAGGAGATCACGATCGCGCTGAAGGACCGCGACGGGCGGGCAGAGGTGACGATCACCGCCTGCGACGGCTGGGCGCGCGGCCCCCGGCGCGACGGGGCGGCGTGGTTGCCCGTGCGGGTCGAGTACGGGGTCGCCGTCATCGGGCCGCTGGAACGCCCCGGCGAACCCGGCTGCGTGACCTGCTTCGAGACCCGCCGGGACCGGGTCAGGACCGACAGCGCCGATCGGGCCGCCGTCCTGGCCGTCCACGGCCCCGAACTCGCCGGGCGGGCCTCCCCGTACCTCGGCCGCCTGGCCGCCCGCACGATCGCGGCCCTGGCCGCGCACGCCGCCGAGGGCCCCGGATGCGCCGTCTGGTACGTCGACCTGCGCACGCTCACCGCCGAACGCCACACGTTCCTGCCGGAACCCCACTGCCCCGACTGCGGCGACCTGCCGGACGACGACCGCGCGTCCGCCGCCTTCGAGCCCGGCGCCGCCCCGCGACCTCCCGGCTACCGGGTCAGGAACGTGCCGGCCGAGCACGGCGCGCTGCTCGACACGTACGTGGACGGCGAATGCGGGCTGATCAGGCCCCTCGTCCGGGACACGCTCGGCGGCCTGGTGATCGCCGGGGCGATGCTGCCGCTGCGGTTCGAGGGCGGTTCGGAGCCCGGCGTGGGCCGCACCCGCGGCTACCGGGCCAGCGAGGTCACCGCCGTGCTCGAAGCGCTCGAACGGTGGGGCGGCGTCGAGCCCGGCGGCAAGCGCACCCGCGTGCGGGCCTCGTACGCGGAGGTGGCCGCGGACGCGCTCGACCCTCGAACGCTGGGCGAGCACGACACCTCCTCCTACGAGATGGAGGGGTTCGCGTTCCGGCCGTTCGCCGAGGACGCCGTCTGCGACTGGGTGTGGGGGTACTCCTTCGCCCGGCGCTCGCCGATCCTCGTGCCGGAGAGCCTGGCCTATTACTACGTACGGGGGCGGGAGCGGCCGTTCCTCTTCGAGATCTCGAACGGGTGCGCGCTCGGCGGCAGCATGGCGGAGGCCCTGCTCTACGGGCTGCTGGAGACGGTCGAGCGGGACGCCTTTCTCATGACCTGGTACGGGCGGCTCCCGGTGCCGCGGATCGACCCCGGCACGGCACGGGACCGCACCATCCCGCTCCAGGCCGCCGCGATCATCGCGGAGACCGGTTATCGGGTGGAGCTGTACGACACGACGATGGAGCACGGCATCCCCAGCGTGTGGGCGATGGGCGTGCGGCAGGACGGCGATCCGGGCAGGCCGCGCCTGGTGTGCGCCGCCGGGGCCCACCTGGTGCCGGAGAAGGCCGTGCTCAGCGCGCTGAGCGAGCTGGGGCCGCTGCTGGCCGACCTGATCCGGCGGTATCCGGACGAGGTGCACCGAGCCCAGGAGATGGTGACAAATCCTGATCTGGTGGCGACGATGCACGACCACTCCACCCTGTACGGCGCCGACGCGGCCTTCGACCGGCTCTCGTTCCTGACCGGCGGCACGGGCGTGCGGGGGCTGCCCGACATGGAGGCGTTCACCGTGCCCGGTGATCTCGACGTCATGAGGGTGGTGGACCGCTTCCTCGCCGAGGGGATGGACGTCGTCGTCATCGACCAGACCACGCCGGAGCATCGGGCCCGCGGTTTCTCCTGCGTCAAGGTGCTGGTGCCCGGCACGCTCCCGATGACCTTCGGCCACCGCAACCGCAGGGTGCGGGGCCTGACCCGCCCGCTGGAGCTGCCGTACCGGCTCGGCCACCGCGACACGCCCCTGACCCCCGCCGACCTGAACCCCGACCCACACCCCTTCCCATGA	MAEVVGTGLLAEEITIALKDRDGRAEVTITACDGWARGPRRDGAAWLPVRVEYGVAVIGPLERPGEPGCVTCFETRRDRVRTDSADRAAVLAVHGPELAGRASPYLGRLAARTIAALAAHAAEGPGCAVWYVDLRTLTAERHTFLPEPHCPDCGDLPDDDRASAAFEPGAAPRPPGYRVRNVPAEHGALLDTYVDGECGLIRPLVRDTLGGLVIAGAMLPLRFEGGSEPGVGRTRGYRASEVTAVLEALERWGGVEPGGKRTRVRASYAEVAADALDPRTLGEHDTSSYEMEGFAFRPFAEDAVCDWVWGYSFARRSPILVPESLAYYYVRGRERPFLFEISNGCALGGSMAEALLYGLLETVERDAFLMTWYGRLPVPRIDPGTARDRTIPLQAAAIIAETGYRVELYDTTMEHGIPSVWAMGVRQDGDPGRPRLVCAAGAHLVPEKAVLSALSELGPLLADLIRRYPDEVHRAQEMVTNPDLVATMHDHSTLYGADAAFDRLSFLTGGTGVRGLPDMEAFTVPGDLDVMRVVDRFLAEGMDVVVIDQTTPEHRARGFSCVKVLVPGTLPMTFGHRNRRVRGLTRPLELPYRLGHRDTPLTPADLNPDPHPFP	MRPLILLASALAMTAPSGALAQSAEQRAKWNGPREPFRITGNLYYVGTSGLSAYLIAGPRGHVLIDGALPESAPLIAANIRKLGFKLSDVKYLLSNHSHVDHAGGLAELKRLTGAQMVANVADKPDLEAGTTIGRTDIADFPAVKVDRVIGDGDRLTLGPIALVAILTPGHTKGATSWTTRIGSKNVIFTSSISVAGQNLINNINYPNAAADFRASFAKLRALKADIFLSFHAEAFALDEKRARAQAGATDAFVDPNELSRQVDLAEKAFDATLAKQQAANADRR	215.44	gnl|BL_ORD_ID|2032|hsp_num:0	2235			201	459	
BGC0000613.1|Thiomuracins_12 # 14252 # 15586 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.746	BGC0000613.1|Thiomuracins_12 	14252	15586	+	Loose	600	27.7202	ICR-Mc	30.19	3004466	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	intrinsic colistin resistant phosphoethanolamine transferase	ATGACCACCGAGCCGTTTCCCGCGCCGACGGGGCCGCCCGCAGCGCCGACGGGGCCGTCTCCCGCGCTGGCGGAGCCGTCTGCTGCATCGCCCGGCCCGTTGTCCGTTCGGCAGGGGCCGTCTCCTGTGACCGCCGAGCTGCGTGACCTGGCGATCTTCCGTGCCGATCTGCATGCCCACCCCGAGCTGTCCTGGCAGGAGGCCAGGACGGCCGATCGCCTGGCGGGGCGGCTGGCGGCGGCCGGGTACGAGGTCACGACCGGGATGGGCGGTCATGGGGTGGTCGGGAGGCTGTGCCGTGGCGACGGGGTCACGGTCATGCTCAGAGCCGAGCTGGACGCCCTCCCCGTCAAGGAGGAGACCGGCCTGTCATACGCCAGCACCGCCACCGCCACGACCCTCGACGGCAGGACGGTGCCGGTCTCCCACGCCTGCGGCCACGACCTCCATCTCGCCTGCCTGGTCGGCGCCGCCCGGCGGCTGGCCGCCTGCGACGACTGGCGGGGCACGGTGCTCGTGATCGGCCAGCCCGCCGAGGAGACGCTGGAGGGCGCCGCCGCGATGCTCGCCGACGGCCTGTACGAGCGGTTCGGCGTCCCGGACGTGGCGCTGGCCCAGCACGTCTCGCCGTTCCCCGCGGGCCTGATCGCCTACCCGGAGCCGCCCACCGCGGCCGGCGCCGAACTCCGCGTCGTCGTCACGGGGGACGGCGGCCACGTCGGAGACATCGGCCGGGCTGGTCACGTCGATCGAGCCGTGGGGCGCAATCCGGTCGCGGCCGTCGCCGCGCTCGTTCACCGGCTCGATCAGACGGCGTTCGACCAGGCGATCGTCACCGTGGGGACGTTGCACGCGGGCGAGCGCGCCAACGTGATCCCCACCCTCGCCGAGGCCGGGATCACGGTCAGGGCCGCGACGGAGGAGGCGGTGACCCGGGCCGTCGCCCGCGTCGCCCGGCTGGCGGAGGAGACGGCGGGAGCCGGCGTCATCGTGGTCTCCAGGGTGCCGCCCGGCGTGAACGACCCCGCCGCCACCGCCCTGGTACGCCGGGCCCACGAGGCCGCGCTCGGCGCGGTCGTCACCGCCCCCGGCGGCTCGGCCTGCGAGGACTTCCCCCTCTACGGGGTGCCCTCCGTCTACTGGTACGTGGGCGCGGCCCCACCCGCCGGCCTGGTCGGACGCCCGCATACCGGGACTTTCCGCCCCGATCCCGTGCCCACGTTGAGGGCAGGGGTCACCGCCATGCAAACGGCTGCCCTGGCAGTCCTTGCGAACGCGTCACAGTTCGCCCCTCCATCCCGATATCATGGACCCGGAGCAGTAGCCGAGCACTGA	MTTEPFPAPTGPPAAPTGPSPALAEPSAASPGPLSVRQGPSPVTAELRDLAIFRADLHAHPELSWQEARTADRLAGRLAAAGYEVTTGMGGHGVVGRLCRGDGVTVMLRAELDALPVKEETGLSYASTATATTLDGRTVPVSHACGHDLHLACLVGAARRLAACDDWRGTVLVIGQPAEETLEGAAAMLADGLYERFGVPDVALAQHVSPFPAGLIAYPEPPTAAGAELRVVVTGDGGHVGDIGRAGHVDRAVGRNPVAAVAALVHRLDQTAFDQAIVTVGTLHAGERANVIPTLAEAGITVRAATEEAVTRAVARVARLAEETAGAGVIVVSRVPPGVNDPAATALVRRAHEAALGAVVTAPGGSACEDFPLYGVPSVYWYVGAAPPAGLVGRPHTGTFRPDPVPTLRAGVTAMQTAALAVLANASQFAPPSRYHGPGAVAEH	MSLKHNQTHNTTFTKFLKSNSFWSKGFWSNRHHRTKDLKGLDAYLFMAIVAIFLTTTANVTFFQQVMSVYPLANYAPFIASLAVVLTGVLLLLLVLLGYRHTLKTVAICFILIAAFAGHFTDTYGTVYDTTMLQNALQTDTAETKDLLSMKLLIRVVLLAGLPICWIIGQPLSFGTLKASLMKRLVTYLVALALVGLPILAFSSQYASFFREHKPLRFFTNPVTVMYSAGKLANMSYKNATKPTETIMHANDAIQKTTASTRKPRLVVMVVGETARADHASFNGYQRATFPHMDKLIGLGQVHNFGNVTSCGTSTAYSVPCMFSYLGAEKYDVDTADYHENVIDTLDRLGVAILWRDNNSDSKGVMNRLPAKQYQDYKNSPLQGGNNTICHTNPYDECRDVGMLVDLDDHVKAHANQDILIVLHQMGNHGPAYYKRYDDEFAQFLPVCTSSELAECERQTVINAYDNALLATDDFLKQTIDWLAAQTHADTAMLYLSDHGESLGEKGVYLHGMPKAFAPKEQLSIPALLWLGADTPFAVANSPTAGFSHDAITPTLLNLFDVSTQATADKTAFVNPLD	76.82	gnl|BL_ORD_ID|2509|hsp_num:0	2902			486	645	colistin A; colistin B
